I agree, the economics are phased, which is a prudent conservative approach in the current environment, but they still have to raise the capital, and it's not easy in the current environment. One thing that killed other early lithium developers was raising capital at any high interest rate, just out of desperation, like accepting 15% or greater rates, which would be a company killer. At current prices, and given Glencore's potential role, then they'd be about breaking even over the first few years, which is better than about 80% to 90% of other lithium developers at the moment. Their economics stack up, and if they can't get this off the ground, then the only new mines that will be successfully built in the near future will be by the biggest global producers who have the cash to carry themselves through the lithium downturn.
If funding is secured for phase 1, then this should be one of the less riskier new project lithium developers.
Gw
- Forums
- ASX - By Stock
- GLN
- Ann: Presentation - RIU Fremantle
Ann: Presentation - RIU Fremantle, page-32
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GLN (ASX) to my watchlist
(20min delay)
|
|||||
Last
15.5¢ |
Change
0.010(6.90%) |
Mkt cap ! $113.0M |
Open | High | Low | Value | Volume |
15.0¢ | 16.5¢ | 15.0¢ | $1.200M | 7.715M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 506022 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 280041 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 506022 | 0.150 |
12 | 833420 | 0.145 |
12 | 1284451 | 0.140 |
9 | 1161295 | 0.135 |
12 | 1623626 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 280041 | 4 |
0.165 | 339195 | 5 |
0.170 | 361695 | 8 |
0.175 | 143030 | 3 |
0.180 | 351786 | 12 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
GLN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online